New from Dr. Lawrence Tablak, NIH Director, a hopeful post describing recent work that may move us a step closer to eliminating latent HIV infection and ultimately finding a cure to end the HIV epidemic. The post features NIH-funded work from a team led by Nadia Roan, Gladstone Institutes, San Francisco and Mohamed Abdel-Mohsen, The Wistar Institute, Philadelphia, PA, whose research used CyTOF to differentiate between different types of immune cells. Read more from Director Tabak’s blog above.
HIV Malignancy Specimens for Research at No Charge